Lung Cancers Completed Phase 1 Trials for Doxorubicin (DB00997)

Also known as: LUng Cancer / Cancer, Lung / Lung neoplasm malignant / Lung cancer NOS / Cancer of lung / Ca lung

IndicationStatusPhase
DBCOND0072929 (Lung Cancers)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00036790Motexafin Gadolinium and Doxorubicin in Treating Patients With Advanced CancerTreatment
NCT00020124Inhaled Doxorubicin in Treating Patients With Advanced Solid Tumors Affecting the LungsTreatment
NCT00004930Inhaled Doxorubicin in Treating Patients With Primary Lung Cancer or Lung MetastasesTreatment